3D printing promised a Manufacturing revolution, then spent a decade disappointing investors. 3D Systems says several of its key markets are now growing more than 20% and its turnaround is gaining traction — just as its long-serving chief executive heads for the exit.

On 3 August 2026, 3D Systems reported second-quarter results that management framed as proof its multi-year turnaround is working: broadly flat headline Revenue but sharply improved profitability, positive first-half adjusted EBITDA, and what the company called strong momentum in key growth markets expanding more than 20%. The market response was emphatic, the shares surging roughly 24%. A day later came a jolt — long-serving chief executive Dr Jeffrey Graves announced he would step down. The juxtaposition frames the central question: is 3D printing, and this bellwether in particular, finally back?

The additive-manufacturing sector has a long history of hype outrunning reality. 3D Systems, a pioneer of the technology, has restructured relentlessly to reach breakeven. So the headline deserves scrutiny: are those 20%-plus growth pockets big enough to move a Business whose overall revenue is barely growing, and does a Leadership change threaten hard-won momentum?

What the Company Does

3D Systems, based in Rock Hill, South Carolina, is one of the original additive-manufacturing companies, selling 3D printers, the materials that feed them, software and engineering services. It reports through two segments. Healthcare Solutions covers medical devices, personalised surgical planning, dental and regenerative or bio-printing applications. Industrial Solutions serves aerospace and defence, automotive, durable goods and, increasingly, data-centre infrastructure, where additive techniques help produce advanced thermal-management and cooling components.

The company positions itself on "market-leading breadth" across both direct-metal and polymer printing technologies. Its revenue mix blends one-off hardware sales — which are lumpy and highly sensitive to customers' Capital Expenditure — with more recurring materials, software and service income. That model suffers when industrial customers rein in capital spending, as many have over the past two years.

Why the Stock Is in Focus

Two catalysts collided. First, the second-quarter print: while total revenue was essentially flat, 3D Systems said key growth markets — including medical technology, aerospace and defence, and data-centre infrastructure — grew more than 20% in the first half, and its cost programme pushed adjusted EBITDA close to breakeven. Investors, primed by years of losses, rewarded evidence that the restructuring is landing; the stock jumped about 24% to around $3.50.

Second, on 4 August the company announced Dr Graves would retire once a successor is found, launching an external search with no internal candidate named. A chief-executive transition midway through a turnaround injects uncertainty precisely when continuity matters most, making the durability of the improvement the key debate for the shares.

Latest Financial Picture

Second-quarter revenue was $94.6m, down 0.3% year on year (up 1.4% excluding divestitures); first-half revenue was $190.1m. Healthcare Solutions grew 6.8% to $48.1m, while Industrial Solutions fell 6.7% to $46.5m (down 3.7% excluding divestitures), reflecting soft industrial capital spending. Gross Margin slipped to 36.4% from 38.1% a year earlier.

The profitability story was the real draw. The net loss narrowed to $12.9m, or $0.09 a share, and adjusted EBITDA improved to negative $0.8m from negative $4.7m a year earlier; first-half adjusted EBITDA was positive at $1.3m. The company cited more than $60m of annualised cost savings from a six-quarter restructuring, with operating expenses down 11% to $39.5m. It ended June with about $128m of cash and roughly $96m of total debt, having completed a $53.2m Equity offering during the quarter. For the third quarter, 3D Systems guided to revenue of $96m–$99m and adjusted EBITDA of negative $3m to negative $1m. (Figures per the company's Q2 2026 release via GlobeNewswire, with commentary from Investing.com and Investing News Network.)

The Bull Case

Bulls will argue the turnaround is real and under-appreciated. Adjusted EBITDA has swung to a positive first-half figure, cost savings exceed $60m annualised, and the fastest-growing end-markets — medical technology, aerospace and defence, and data-centre infrastructure — are structurally attractive, secular-growth areas rather than purely cyclical ones. If those 20%-plus growth pockets keep compounding, they should gradually re-weight the mix toward growth and margin. A recent equity raise and roughly $128m of cash provide runway. At around $3.50 the shares trade far below past highs, so even a modest but sustained return to group growth could support a re-rating. On our reading, the profitability inflection is the most encouraging the company has shown in years.

The Bear Case

The bear case is equally grounded. Total revenue is still not growing — the 20%-plus markets remain too small to offset weakness in the broader industrial base, where sales fell. Gross margin declined year on year, the company is still loss-making, and third-quarter EBITDA guidance points back to negative territory. The $53.2m equity raise dilutes existing shareholders, a reminder that cash generation is not yet self-sustaining. Hardware Demand remains hostage to industrial capital-spending cycles that are still soft. And the chief executive's departure mid-turnaround adds execution and strategic risk just as investors were regaining confidence. A 24% one-day pop also raises the bar for future delivery.

What Could Move the Stock Next?

The most important near-term catalyst is the chief-executive succession: who is appointed, and whether they maintain the current strategy. Third-quarter results — guided to $96m–$99m of revenue — will test whether the growth markets keep expanding and whether adjusted EBITDA can hold near breakeven. Investors should watch industrial capital-spending trends, order momentum in aerospace, defence and data-centre applications, further delivery of the cost-savings programme, and the Balance Sheet after the recent raise. Any new large customer programmes, partnerships or additional divestitures could also move the shares.

Outlook

Is 3D printing finally back? On the evidence to 12 August 2026, 3D Systems is making genuine progress: positive first-half adjusted EBITDA, more than $60m of cost savings and real momentum in medical, aerospace and data-centre markets are not trivial achievements. But "back" overstates it. Group revenue is flat, margins have slipped, losses persist, and the company has just leaned on shareholders for fresh equity. Layer on a chief-executive transition mid-turnaround and the picture is one of a business stabilising rather than surging. On our reading, the second quarter validates the turnaround thesis without yet proving it; the next two quarters, and the incoming chief executive, will decide whether traction becomes lift-off.